Belantamab mafodotin - CAS 2050232-20-5

Belantamab mafodotin - CAS 2050232-20-5 Catalog number: BADC-01607

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Belantamab mafodotin is an antibody-drug conjugate consisting of an antibody targeting B-cell maturation antigen (BCMA) conjugated to the microtubule inhibitor monomethyl auristatin F (MMAF). Belantamab mafodotin has been approved for the treatment of multiple myeloma.

Category
Antibody-Drug Conjugates (ADCs)
Product Name
Belantamab mafodotin
CAS
2050232-20-5
Catalog Number
BADC-01607

Ordering Information

Catalog Number Size Price Quantity
BADC-01607 -- $--
Inquiry
Description
Belantamab mafodotin is an antibody-drug conjugate consisting of an antibody targeting B-cell maturation antigen (BCMA) conjugated to the microtubule inhibitor monomethyl auristatin F (MMAF). Belantamab mafodotin has been approved for the treatment of multiple myeloma.
Synonyms
GSK2857916; Belantamab mafodotin-blm
Appearance
Liquid
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Send Inquiry
Verification code
Inquiry Basket